BFRG Stock More Than Doubled Today — What Is Fueling The Surge?

Bullfrog AI stated that this agreement is intended to accelerate the pharmaceutical company’s drug discovery and clinical development programs.
Representative image of a trending stock chart.
Representative image of a trending stock chart. (Photo: Getty Images)
Profile Image
Rounak Jain·Stocktwits
Published Mar 30, 2026   |   8:05 AM EDT
Share
·
Add us onAdd us on Google

Bullfrog AI Holdings Inc. (BFRG) shares gained more than 114% in Monday’s pre-market trade after the company announced a deal with a major global pharmaceutical giant.

Bullfrog AI stated that its agreement requires the company to use its bfLEAP program to identify and prioritize novel drug targets in major depressive disorder (MDD). The company stated that this is aimed at accelerating its drug discovery and clinical development programs.

Retail sentiment on Stocktwits around Bullfrog AI trended in the ‘extremely bullish’ territory with message volumes at ‘high’ levels at the time of writing.

Get updates to this developing story directly on Stocktwits.

Also See: VRDN Stock Plummeted 41% Pre-Market Today — What Did Its Phase 3 Active Thyroid Eye Disease Trial Reveal?

For updates and corrections, email newsroom[at]stocktwits[dot]com.

Follow on Google News
Read about our editorial guidelines and ethics policy